Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.
China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.
The report details the trend, potential and market size of Anti-cancer Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-cancer Drugmarket, defines the market attractiveness level of Anti-cancer Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-cancer Drug industry, describes the types of Anti-cancer Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-cancer Drug market and the development prospects and opportunities of Anti-cancer Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-cancer Drug market in Chapter 13.
By Player:
Boehringer Ingelheim GmbH
Hoffmann-La Roche Ltd
Pfizer
Bayer
Ariad Pharmaceuticals
Bristol-Myers Squibb
Amgen
Teva Pharmaceuticals
Merck
Sanofi
GlaxoSmithKline
Novartis
Celgene Corporation
Eli Lilly
AstraZeneca
By Type:
Avastin
Rituxan
Herceptin
Alimta
By End-User:
Hospital
Clinic
Home Care
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-cancer Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-cancer Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-cancer Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-cancer Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-cancer Drug Market Analysis and Outlook to 2022
-
7.1 Global Anti-cancer Drug Consumption (2017-2022)
-
7.2 United States Anti-cancer Drug Consumption (2017-2022)
-
7.3 Europe Anti-cancer Drug Consumption (2017-2022)
-
7.4 China Anti-cancer Drug Consumption (2017-2022)
-
7.5 Japan Anti-cancer Drug Consumption (2017-2022)
-
7.6 India Anti-cancer Drug Consumption (2017-2022)
-
7.7 South Korea Anti-cancer Drug Consumption (2017-2022)
8 Region and Country-wise Anti-cancer Drug Market Analysis and Outlook to 2028
-
8.1 Global Anti-cancer Drug Consumption Forecast (2022-2028)
-
8.2 United States Anti-cancer Drug Consumption Forecast (2022-2028)
-
8.3 Europe Anti-cancer Drug Consumption Forecast (2022-2028)
-
8.4 China Anti-cancer Drug Consumption Forecast (2022-2028)
-
8.5 Japan Anti-cancer Drug Consumption Forecast (2022-2028)
-
8.6 India Anti-cancer Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-cancer Drug Consumption Forecast (2022-2028)
9 Global Anti-cancer Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-cancer Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Avastin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rituxan Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Herceptin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Alimta Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-cancer Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)
10 Global Anti-cancer Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-cancer Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Avastin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rituxan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Herceptin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Alimta Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-cancer Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-cancer Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-cancer Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-cancer Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-cancer Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-cancer Drug Market Competitive Analysis
-
14.1 Boehringer Ingelheim GmbH
-
14.1.1 Boehringer Ingelheim GmbH Company Details
-
14.1.2 Boehringer Ingelheim GmbH Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Boehringer Ingelheim GmbH Anti-cancer Drug Product and Service
-
14.2 Hoffmann-La Roche Ltd
-
14.2.1 Hoffmann-La Roche Ltd Company Details
-
14.2.2 Hoffmann-La Roche Ltd Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Hoffmann-La Roche Ltd Anti-cancer Drug Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Anti-cancer Drug Product and Service
-
14.4 Bayer
-
14.4.1 Bayer Company Details
-
14.4.2 Bayer Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bayer Anti-cancer Drug Product and Service
-
14.5 Ariad Pharmaceuticals
-
14.5.1 Ariad Pharmaceuticals Company Details
-
14.5.2 Ariad Pharmaceuticals Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Ariad Pharmaceuticals Anti-cancer Drug Product and Service
-
14.6 Bristol-Myers Squibb
-
14.6.1 Bristol-Myers Squibb Company Details
-
14.6.2 Bristol-Myers Squibb Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bristol-Myers Squibb Anti-cancer Drug Product and Service
-
14.7 Amgen
-
14.7.1 Amgen Company Details
-
14.7.2 Amgen Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Amgen Anti-cancer Drug Product and Service
-
14.8 Teva Pharmaceuticals
-
14.8.1 Teva Pharmaceuticals Company Details
-
14.8.2 Teva Pharmaceuticals Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Teva Pharmaceuticals Anti-cancer Drug Product and Service
-
14.9 Merck
-
14.9.1 Merck Company Details
-
14.9.2 Merck Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck Anti-cancer Drug Product and Service
-
14.10 Sanofi
-
14.10.1 Sanofi Company Details
-
14.10.2 Sanofi Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sanofi Anti-cancer Drug Product and Service
-
14.11 GlaxoSmithKline
-
14.11.1 GlaxoSmithKline Company Details
-
14.11.2 GlaxoSmithKline Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 GlaxoSmithKline Anti-cancer Drug Product and Service
-
14.12 Novartis
-
14.12.1 Novartis Company Details
-
14.12.2 Novartis Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Novartis Anti-cancer Drug Product and Service
-
14.13 Celgene Corporation
-
14.13.1 Celgene Corporation Company Details
-
14.13.2 Celgene Corporation Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Celgene Corporation Anti-cancer Drug Product and Service
-
14.14 Eli Lilly
-
14.14.1 Eli Lilly Company Details
-
14.14.2 Eli Lilly Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Eli Lilly Anti-cancer Drug Product and Service
-
14.15 AstraZeneca
-
14.15.1 AstraZeneca Company Details
-
14.15.2 AstraZeneca Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 AstraZeneca Anti-cancer Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-cancer Drug
-
Figure Anti-cancer Drug Picture
-
Table Global Anti-cancer Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-cancer Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-cancer Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-cancer Drug Consumption by Country (2017-2022)
-
Figure United States Anti-cancer Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure China Anti-cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure India Anti-cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-cancer Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Avastin Consumption and Growth Rate (2017-2022)
-
Figure Global Rituxan Consumption and Growth Rate (2017-2022)
-
Figure Global Herceptin Consumption and Growth Rate (2017-2022)
-
Figure Global Alimta Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Home Care Consumption and Growth Rate (2017-2022)
-
Figure Global Avastin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rituxan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Herceptin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alimta Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-cancer Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-cancer Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim GmbH Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Anti-cancer Drug Product and Service
-
Table Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table Hoffmann-La Roche Ltd Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffmann-La Roche Ltd Anti-cancer Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Anti-cancer Drug Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Anti-cancer Drug Product and Service
-
Table Ariad Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Ariad Pharmaceuticals Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ariad Pharmaceuticals Anti-cancer Drug Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Anti-cancer Drug Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Anti-cancer Drug Product and Service
-
Table Teva Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceuticals Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceuticals Anti-cancer Drug Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Anti-cancer Drug Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Anti-cancer Drug Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Anti-cancer Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Anti-cancer Drug Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Anti-cancer Drug Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Anti-cancer Drug Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Anti-cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Anti-cancer Drug Product and Service
-
